PERRONE, GABRIELE
 Distribuzione geografica
Continente #
NA - Nord America 2.369
EU - Europa 1.932
AS - Asia 1.037
SA - Sud America 88
AF - Africa 27
OC - Oceania 12
Totale 5.465
Nazione #
US - Stati Uniti d'America 2.335
PL - Polonia 783
RU - Federazione Russa 526
SG - Singapore 331
CN - Cina 246
IT - Italia 187
HK - Hong Kong 169
IE - Irlanda 98
VN - Vietnam 93
SE - Svezia 88
BR - Brasile 70
DE - Germania 69
KR - Corea 59
FR - Francia 39
FI - Finlandia 35
GB - Regno Unito 32
JO - Giordania 27
IN - India 25
JP - Giappone 23
CA - Canada 17
ES - Italia 16
CH - Svizzera 15
IQ - Iraq 13
ZA - Sudafrica 12
ID - Indonesia 11
AT - Austria 10
AU - Australia 10
MX - Messico 10
AR - Argentina 9
BD - Bangladesh 9
NL - Olanda 9
TR - Turchia 7
PK - Pakistan 6
UA - Ucraina 6
BE - Belgio 4
CI - Costa d'Avorio 4
DZ - Algeria 4
UZ - Uzbekistan 4
GR - Grecia 3
MA - Marocco 3
PH - Filippine 3
SA - Arabia Saudita 3
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
JM - Giamaica 2
NG - Nigeria 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BB - Barbados 1
BH - Bahrain 1
BO - Bolivia 1
CO - Colombia 1
EC - Ecuador 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
LT - Lituania 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TN - Tunisia 1
Totale 5.465
Città #
Warsaw 777
Santa Clara 474
Ashburn 313
Singapore 223
Fairfield 154
Hong Kong 142
Chandler 129
San Jose 107
Dublin 98
Beijing 83
Houston 82
Cambridge 79
Seattle 79
Woodbridge 70
Wilmington 60
Seoul 58
The Dalles 51
Florence 47
Ann Arbor 44
Altamura 36
Buffalo 35
Lawrence 32
New York 30
Los Angeles 29
Princeton 27
Council Bluffs 25
Bremen 23
Dallas 21
Ho Chi Minh City 21
Boston 20
Tokyo 20
Lauterbourg 19
Munich 19
Shanghai 19
Hanoi 18
Helsinki 17
Boardman 16
Medford 15
Mumbai 15
Paris 15
Bern 14
Hefei 14
Clifton 13
Kent 13
Johannesburg 11
Moscow 11
Phoenix 11
Melbourne 10
San Diego 10
Barcelona 9
Jakarta 9
Dong Ket 8
London 8
Norwich 8
Redondo Beach 8
Toronto 8
Jacksonville 7
Orem 7
São Paulo 7
Vienna 7
Chicago 6
Da Nang 5
Guangzhou 5
Milan 5
Norwalk 5
Rome 5
Stockholm 5
Abidjan 4
Amsterdam 4
Brooklyn 4
Cagliari 4
Dearborn 4
Falls Church 4
Haiphong 4
Hải Dương 4
Lappeenranta 4
Mexico City 4
Tashkent 4
Tianjin 4
Baghdad 3
Brasília 3
Brussels 3
Dhaka 3
Frankfurt am Main 3
Latina 3
Mosul 3
Newark 3
San Francisco 3
Shenzhen 3
Sinalunga 3
Suzhou 3
Turin 3
Turku 3
Vancouver 3
Wuhan 3
Abuja 2
Athens 2
Belo Horizonte 2
Blumenau 2
Bologna 2
Totale 3.877
Nome #
RNA sequencing reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 347
The Inhibitory Effects of HYDAMTIQ, a Novel PARP Inhibitor, on Growth in Human Tumor Cell Lines With Defective DNA Damage Response Pathways. 331
Identificazione di MTHFR 1298A>C come marcatore predittivo di sopravvivenza in due coorti di pazienti con carcinoma colorettale (stadio II e III) trattati con chemioterapia adiuvante a base di fluoropirimidine con o senza oxaliplatino 314
Proteomic analysis of A2780/S ovarian cancer cell response to the cytotoxic organogold(III) compound Aubipy(c.) 309
Druggable Targets in Pancreatic Adenocarcinoma 305
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin 264
Selection and characterization of a human ovarian cancer cell line resistant to auranofin 243
Epigenetics and chemoresistance in colorectal cancer: An opportunity for treatment tailoring and novel therapeutic strategies 243
A transcriptomic profile predicts clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 230
Chemistry and Biology of Two Novel Gold(I) Carbene Complexes as Prospective Anticancer Agents 225
RNA sequencing reveals PNN and KCNQ1OT1 as predictive biomarkers of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 212
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma 205
Fluoropyrimidine-related toxicity in gastrointestinal cancer patients. Assessment of risk factors. 200
THE IMPACT OF GENETIC POLYMORPHISMS ON R-CHOP EFFICACY IN DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS: AN INTERIM ANALYSIS OF A MULTICENTER PROSPECTIVE PHARMACOGENETIC STUDY 196
Identification Of Pharmacogenomic Markers Of Clinical Efficacy In A Dose-Dense Therapy Regimen (R-Chop14) In Diffuse Large B Cell Lymphoma 193
Role of Genetic Polymorphisms on Response to R-CHOP regimen in Diffuse Large B-cell Lymphoma Patients: an Interim Analysis of a Multicenter Prospective Pharmacogenetic Study 191
Global gene expression profile reveals a distinct transcriptomic profile predictive of clinical outcome in stage III colorectal cancer patients treated with adjuvant chemotherapy 186
Role of genetic polymorphisms on R-CHOP efficacy in diffuse large B-cell lymphoma patients: an interim analysis of a multicenter prospective pharmacogenetics study. 180
PNN and KCNQ1OT1 can predict the efficacy of adjuvant fluoropyrimidine-based chemotherapy in colorectal cancer patients 176
Vinorelbine in non-small cell lung cancer: Real-World data from a single institution experience 160
Pharmacological modulation of protein kinase C for overcoming drug resistance in colorectal cancer. Preliminary results of in vitro studies. 157
Pharmacogenomic Markers of Clinical Efficacy in a Dose-Dense Therapy Regimen (R-CHOP14) in Diffuse Large B Cell Lymphoma 145
Erratum: The inhibitory effects of HYDAMTIQ, a novel PARP inhibitor, on growth in human tumor cell lines with defective DNA damage response pathways (Oncology Research 25:9 (1441-1451) DOI: 10.3727/096504017X14926854178616) 144
Pharmacogenomic markers of clinical efficacy in a dose-dense therapy regimen (R-CHOP14) in diffuse large B cell lymphoma: preliminary results 129
Pharmacogenetics in diffuse large B-cell lymphoma treated with R-CHOP: Still an unmet challenge 124
Validation of single nucleotide polymorphisms potentially related to R-CHOP resistance in diffuse large B-cell lymphoma patients 112
Totale 5.521
Categoria #
all - tutte 13.913
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.913


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202142 0 0 0 0 0 0 0 0 0 0 20 22
2021/2022178 6 6 7 6 3 17 4 21 12 14 26 56
2022/2023576 47 116 34 57 36 86 59 28 69 1 12 31
2023/2024248 4 21 30 10 11 27 27 72 6 7 15 18
2024/20251.399 56 128 89 236 396 190 19 90 64 41 46 44
2025/20261.503 191 179 79 126 232 77 233 93 100 151 42 0
Totale 5.521